TriangleNCT00392327 · OUTCOME
The Estimated Full-scale IQ (FSIQ) at 30+/-6 Months Post Diagnosis for SPNET Patients
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEAN
- Unit
- Score on a scale
- Interval / dispersion
- Standard Deviation
- Time frame
- 24 - 36 months post diagnosis
What was measured
Post-treatment neurocognitive function was assessed. Full-scale IQ (FSIQ) is a representative measurement for neurocognitive function. FSIQ was measured by IQ tests. Assessments within the time window, from eligible and evaluable patients are reported. The time window is 30+/-6 months post diagnosis, only the assessments before progression date were reported. The Range of FSIQ is 50-150. A higher FSIQ is better. Mean and standard deviation of FSIQ were calculated and reported.
Analysis population: Eligible SPNET patients are included
Groups in this outcome
Regimen A (SPNET Patients)
SPNET patients who received regimen A (no carboplatin / no isotretinoin)
Regimen B (SPNET Patients)
SPNET patients who received regimen B (carboplatin / no isotretinoin)
Regimen C (SPNET Patients)
SPNET patients who received regimen C (no carboplatin / isotretinoin)
Regimen D (SPNET Patients)
SPNET patients who received regimen D (carboplatin / isotretinoin)
| Group | Source count |
|---|---|
| Regimen A (SPNET Patients) | 4 |
| Regimen B (SPNET Patients) | 2 |
| Regimen C (SPNET Patients) | 3 |
| Regimen D (SPNET Patients) | 6 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Regimen A (SPNET Patients) | 83.3 | 9.98 | Not reported | Not reported | Not reported |
| Regimen B (SPNET Patients) | 57.5 | 2.12 | Not reported | Not reported | Not reported |
| Regimen C (SPNET Patients) | 83.7 | 4.04 | Not reported | Not reported | Not reported |
| Regimen D (SPNET Patients) | 88.5 | 20.95 | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- spread
- 9.98
- value
- 83.3
- group Id
- OG001
- spread
- 2.12
- value
- 57.5
- group Id
- OG002
- spread
- 4.04
- value
- 83.7
- group Id
- OG003
- spread
- 20.95
- value
- 88.5
- denoms
- counts
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 2
- group Id
- OG002
- value
- 3
- group Id
- OG003
- value
- 6
- units
- Participants
- description
- Post-treatment neurocognitive function was assessed. Full-scale IQ (FSIQ) is a representative measurement for neurocognitive function. FSIQ was measured by IQ tests. Assessments within the time window, from eligible and evaluable patients are reported. The time window is 30+/-6 months post diagnosis, only the assessments before progression date were reported. The Range of FSIQ is 50-150. A higher FSIQ is better. Mean and standard deviation of FSIQ were calculated and reported.
- dispersion Type
- Standard Deviation
- groups
- description
- SPNET patients who received regimen A (no carboplatin / no isotretinoin)
- id
- OG000
- title
- Regimen A (SPNET Patients)
- description
- SPNET patients who received regimen B (carboplatin / no isotretinoin)
- id
- OG001
- title
- Regimen B (SPNET Patients)
- description
- SPNET patients who received regimen C (no carboplatin / isotretinoin)
- id
- OG002
- title
- Regimen C (SPNET Patients)
- description
- SPNET patients who received regimen D (carboplatin / isotretinoin)
- id
- OG003
- title
- Regimen D (SPNET Patients)
- param Type
- MEAN
- population Description
- Eligible SPNET patients are included
- reporting Status
- POSTED
- time Frame
- 24 - 36 months post diagnosis
- title
- The Estimated Full-scale IQ (FSIQ) at 30+/-6 Months Post Diagnosis for SPNET Patients
- type
- SECONDARY
- unit Of Measure
- Score on a scale
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice